Marites Pilapil, APRN
Nurse Practitioner · Henderson, NVNPI 1952752511
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 586 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 49 manufacturers reported payments, led by AbbVie at 27.9% of the total. Among nurse practitioner clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 586 payments — averaging $18.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Neurocrine Biosciences, Inc.$1K
- Novartis$628
- Lundbeck LLC$565
- UCB, Inc.$537
- Pfizer$471
- plus $5K from 43 others
What the payments were for
- Speaking & faculty fees$120%
- Food & beverage$11,082100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFINITY$165
- NURTEC ODT$125
- ZEPOSIA$104
How this compares
$11,094 in reported general payments places this provider in the 95th percentile of 933 nurse practitioner providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nurtec OdtRimegepant Sulfate | 27 | $45,461 |
| UbrelvyUbrogepant | 27 | $41,875 |
| QuliptaAtogepant | 19 | $19,898 |
| Aimovig AutoinjectorErenumab-Aooe | 24 | $16,127 |
| Levetiracetam | 155 | $4,941 |
| Lacosamide | 31 | $4,753 |
| Memantine Hcl | 296 | $4,536 |
| Tegretol XrCarbamazepine | 12 | $4,295 |
| Gabapentin | 324 | $3,283 |
| Pregabalin | 116 | $2,773 |
| Galantamine Hbr | 31 | $2,530 |
| Duloxetine Hcl | 215 | $2,299 |
| Pyridostigmine Bromide | 21 | $2,286 |
| Divalproex Sodium ErDivalproex Sodium | 93 | $1,846 |
| Carbamazepine ErCarbamazepine | 11 | $1,628 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy, Qulipta | $3,096 | $61,77346 claims |
| PfizerNurtec Odt | $471 | $45,46127 claims |
| Amneal Pharmaceuticals LLCPyridostigmine Bromide | $152 | $2,28621 claims |
| Upsher-smith Laboratories LLCTopiramate | $71 | $844103 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 933 nurse practitioner providers in Nevada.
Other nurse practitioner in Henderson
- Charina TosteHenderson$393K
- Jackie ArmijoHenderson$11K
- Arianny Perrino LanzHenderson$9K
- Natalie HuxtableHenderson$7K
- Tiffany ShowHenderson$7K
- Stefanie RemsonHenderson$7K
- Bethany BairdHenderson$6K
- Melanie SpeedLas Vegas$80K
- Shelley MilesLas Vegas$34K
- Nasslynne LenzLas Vegas$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.